Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin vaginal cream plus oral metronidazole versus oral metronidazole for bacterial vaginosis
PACTR202510895720817Phase 0Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of clindamycin and metronidazole in bacterial vaginosis (BV) (3 arms), sponsored by Ain Shams University. Primary endpoint: Clinical and microbiological efficacy. Started Jan 2024; status: completed.
02
Drugs
clindamycinmetronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on PACTR202510895720817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510895720817.